secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001193125-25-098817
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics regains Nasdaq minimum bid price compliance
----------------------------------------------------------------

- Received Nasdaq notice on April 24, 2025 confirming compliance with Listing Rule 5550(a)(2).
- Rule requires minimum bid price of $1.00 per share for continued listing.
- Company had previously been notified of deficiency; now resolved.
- No other regulatory or operational updates provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/0001193125-25-098817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312525098817/d935409d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-098817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer